Acta Med. 2002, 45: 155-160

https://doi.org/10.14712/18059694.2019.73

Diagnostic Value of C-Reactive Protein in Patients with Angiographically Documented Coronary Heart Disease

Esin Erena, Necat Yılmaza, Sadrettin Pençeb, Hasan Koçoğluc, Sıtkı Göksuc, Ramazan Kocabaşa, Sinan Kadayıfcıd

aGaziantep University Medical School, Department of Biochemistry, Gaziantep, Turkey
bGaziantep University Medical School, Department of Physiology, Gaziantep, Turkey
cGaziantep University Medical School, Department of Anestesiology and Reanimation, Gaziantep, Turkey
dGaziantep State Hospital, Department of Cardiology, Gaziantep, Turkey

Received October 1, 2001
Accepted May 1, 2002

References

1. Abdelmouttaleb I, Danchin N, Ilardo C, Aimone-Gastin I, Le Faou A. C-reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes. Am Heart J 1999; 2:346–51. <https://doi.org/10.1053/hj.1999.v137.92052>
2. Baltz ML, de Beer FC, Feinstein A et al. Pylogenetic aspects of C-reactive protein and related proteins. Ann NY Acad Sci 1982; 389:49–75. <https://doi.org/10.1111/j.1749-6632.1982.tb22125.x>
3. Bhakdi S, Torzewski M, Klouche M, Hemmes M. Complement activation and atherogenesis. Binding of CRP to degraded, nonoxidised LDL enhances complement activation. Arterioscler Thromb Vasc Biol 1999; 19:2348–54. <https://doi.org/10.1161/01.ATV.19.10.2348>
4. Cermak JC, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993; 82:513–20.
5. Danesh J, Collins R, Applebly P, Peto R. Association of fibrinogen , C-reactive protein, albumin or leukocyte count with coronary heart disease. Jama 1998; 279:1477–88. <https://doi.org/10.1001/jama.279.18.1477>
6. de Beer FC, Soutar AK, Baltz ML, Trayner I, Feinstein A, Pepys MB. Low density and very low density lipoproteins are selectively bound by aggregated C-reactive protein. J Exp Med 1982; 156:230–42. <https://doi.org/10.1084/jem.156.1.230> <PubMed>
7. Ferreiros ER, Boissonnet CP, Pizarro R et al. Independent prognostic value of elevated C-reactive protein in unstable angina. Circulation 1999; 100(19):1958–63. <https://doi.org/10.1161/01.CIR.100.19.1958>
8. Folsom AR, Pankow JS, Tracy RP et al. Association of C-reactive protein with markers of prevalent atherosclerotic disease. Am J Cardiol 2001; 88(2):112–7. <https://doi.org/10.1016/S0002-9149(01)01603-4>
9. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18(6):499–502.
10. Griselli M, Herbert J, Hutchinson WL et al. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J Exp Med 1999; 190(12):1733–40. <https://doi.org/10.1084/jem.190.12.1733> <PubMed>
11. Hack CE, Wolbink GJ, Schalkwijk C, Speijer H, Hermens WT, van den Bosch H. A role for secretory phospholipase A2 and C-reactive proteins in the removal of injured cells. Immunol Today 1997; 18:111–5. <https://doi.org/10.1016/S0167-5699(97)01002-5>
12. Haidari M, Jaradi E, Sadeghi B, Hajilasi M, Ghanbili J. Evaluation of C-reactive protein asensitive marker of inflammation as risk factor for stable coronary artery disease. Clin Biochem 2001; 33:309–15. <https://doi.org/10.1016/S0009-9120(01)00227-2>
13. Judkins MP. Selective coronary arteriography. I. A percutaneous transfemoral technique. Radiology 1967; 89:815–24. <https://doi.org/10.1148/89.5.815>
14. Kuller LH, Tracy RP, Shaten J, Meilahn EN. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol 1996; 144:537–47.
15. Kuller LH, Tracy RP. The role of inflammation in cardiovascular disease. Arterioscler Thromb Vasc Biol 2000; 20(4):901–6. <https://doi.org/10.1161/01.ATV.20.4.901>
16. Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 1997; 43(1):52–8.
17. Onat A, Sansoy V, Yildirim B, Keles I, Uysal O and Hergenc G. C-reactive protein and coronary heart disease in western Turkey. Am J Cardiol 2001; 88(6):601–7. <https://doi.org/10.1016/S0002-9149(01)01799-4>
18. Pasceri V, Wu HD, Willerson JT, Yeh ET. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. Circulation 2000; 101:235–8. <https://doi.org/10.1161/01.CIR.101.3.235>
19. Pepys MB, The acute phase response with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol 1983; 34:141–212. <https://doi.org/10.1016/S0065-2776(08)60379-X>
20. Pepys MB, Dash AC, Fletcher TC, Richardson N, Munn EA, Feinstein A. Analogs in other mammals and in fish of human plasma proteins C- reactive protein and amyloid P component. Nature 1978; 273:168–70. <https://doi.org/10.1038/273168a0>
21. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342(12):836–43. <https://doi.org/10.1056/NEJM200003233421202>
22. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998; 97:425–8. <https://doi.org/10.1161/01.CIR.97.5.425>
23. Rifai N, Joubran R, Yu H, Asmi M, Jouma M. Inflammatory markers in men with angiographically documented coronary heart disease. Clin Chem. 1999; 45(11): 1967–73.
24. Rifai N, Tracy RP, Ridker PM. Clinical efficacy of an automated high sensitivity C-reactive protein assay. Clin Chem 1999; 45(12):2136–41.
25. Shah PK. Circulating markers of inflammation for vascular risk prediction: Are they ready for prime time. Circulation 2000; 101(15):1758–65. <https://doi.org/10.1161/01.CIR.101.15.1758>
26. Thompson D, Pepys MB, Wood SP. The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 1999; 7:169–77. <https://doi.org/10.1016/S0969-2126(99)80023-9>
27. Whicher J, Biasucci L, Rifai N. Inflammation, the acute phase response and atherosclerosis. Clin Chem Lab Med 1999; 37(5):495–503. <https://doi.org/10.1515/CCLM.1999.080>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive